-
Innovation Ranking
NewInnovation Ranking – AF Gruppen ASA
AF Gruppen ASA (AF Gruppen) is a construction contractor. It carries out heavy construction projects in six business areas including property, building, civil engineering, environment and energy, and offshore. The company provides civil engineering services for projects such as roads, rail, foundation work, airports, fitting, building, and securing tunnels. It also carries out new construction work, upgrading of oil and gas installations, besides port facilities. The company offers development and leasing services for commercial, residential, and public sector buildings. It...
-
Product Insights
AF Power Solar PV Park I
AF Power Solar PV Park I is a solar PV project located in Bulawayo, Zimbabwe. The project is at the permitting stage. Empower your strategies with our AF Power Solar PV Park I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
AF Power Solar PV Park II
AF Power Solar PV Park II is a solar PV project located in Zimbabwe. The project is owned and being developed by AF Power Pte Ltd; Zimbabwe Investment and Development Agency. The project is at the permitting stage. Empower your strategies with our AF Power Solar PV Park II report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANAVEX-371 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANAVEX-371 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANAVEX-371 in Parkinson's Disease Drug Details: ANAVEX 3-71 (AF-710B) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Incobotulinumtoxin A in Peripheral Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Incobotulinumtoxin A in Peripheral Neuropathic Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Incobotulinumtoxin A in Peripheral Neuropathic Pain Drug Details: Incobotulinumtoxin A...
-
Product Insights
NewLeft Atrial Appendage Closure Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Left Atrial Appendage Closure Devices Pipeline Market Report Overview Left atrial appendage closure device prevents blood flow into the left atrial appendage, preventing blood clotting or pooling. It consists of left atrial appendage implanted occlusion devices and left atrial appendage ligation devices. One unit refers to one left atrial appendage closure device. The left atrial appendage closure devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development....
-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-284 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-284 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-284 in Diffuse Large B-Cell Lymphoma Drug Details: LP-284...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-284 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-284 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-284 in Solid Tumor Drug Details: LP-284 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LP-284 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LP-284 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LP-284 in Mantle Cell Lymphoma Drug Details: LP-284 is under...